Partners Capital Investment Group, LLP Bei Gene, Ltd. Transaction History

Partners Capital Investment Group, LLP

$5.87 Billion
Q3 2024

A detailed history of Partners Capital Investment Group, LLP transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Partners Capital Investment Group, LLP holds 11,041 shares of BGNE stock, worth $1.95 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,041

Previous 12,379 10.81%

Holding current value

$1.95 Million

Previous $1.77 Million 40.32%

% of portfolio

0.04%

Previous 0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$143.93 - $224.51 $192,578 - $300,394	-1,338 Reduced 10.81%	11,041 $2.48 Million
Q2 2024 Aug 13, 2024	BUY	$129.52 - $174.32 $1.6 Million - $2.16 Million	12,379 New	12,379 $1.77 Million
Q4 2023 Feb 12, 2024	BUY	$158.67 - $201.58 $2.43 Million - $3.09 Million	15,316 New	15,316 $2.76 Million
Q3 2022 Nov 14, 2022	SELL	$131.8 - $202.24 $2.41 Million - $3.7 Million	-18,311 Closed	0 $0
Q2 2022 Aug 15, 2022	SELL	$121.11 - $216.05 $16.4 Million - $29.2 Million	-135,081 Reduced 88.06%	18,311 $2.96 Million
Q1 2022 May 16, 2022	BUY	$146.52 - $269.56 $5.39 Million - $9.92 Million	36,794 Added 31.56%	153,392 $28.9 Million
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $1.11 Million - $1.73 Million	4,452 Added 3.97%	116,598 $31.6 Million
Q3 2021 Nov 15, 2021	SELL	$249.6 - $403.14 $199,680 - $322,512	-800 Reduced 0.71%	112,146 $40.7 Million
Q2 2021 Aug 16, 2021	BUY	$292.75 - $367.01 $1.72 Million - $2.16 Million	5,889 Added 5.5%	112,946 $38.8 Million
Q1 2021 May 17, 2021	BUY	$260.64 - $382.12 $21.2 Million - $31 Million	81,162 Added 313.43%	107,057 $37.3 Million
Q4 2020 Feb 16, 2021	BUY	$221.31 - $316.61 $714,609 - $1.02 Million	3,229 Added 14.25%	25,895 $6.69 Million
Q3 2020 Nov 13, 2020	SELL	$189.18 - $286.44 $479,571 - $726,125	-2,535 Reduced 10.06%	22,666 $6.49 Million
Q2 2020 Aug 12, 2020	SELL	$123.9 - $195.41 $495,600 - $781,640	-4,000 Reduced 13.7%	25,201 $4.75 Million
Q4 2019 Feb 13, 2020	BUY	$115.78 - $208.34 $3.38 Million - $6.08 Million	29,201 New	29,201 $4.84 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.3B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Partners Capital Investment Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Partners Capital Investment Group, LLP with notifications on news.

Account

Partners Capital Investment Group, LLP Bei Gene, Ltd. Transaction History